Global Helicobacter Pylori Testing Market

Helicobacter Pylori Testing Comprehensive Study by Type (With Endoscopy, Without Endoscopy), Application (Physical Examination Center, Hospitals, Clinics, Others), Tests (Blood Antibody Test, Urea Breath Test, Stool Antigen Test, Stomach Biopsy, Others) Players and Region - Global Market Outlook to 2030

Helicobacter Pylori Testing Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 4.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Helicobacter Pylori Testing
The helicobacter pylori testing is used for the testing of a type of bacteria or germs which have entered into the body and live in the digestive tract of the body which causes infection like sores, called ulcers in the lining of the stomach or the upper part of the intestine. This problem left untreated can lead to stomach cancer, the testing helps in the diagnosis of the disease and treat it accordingly. The H.pylori infections are asymptomatic, but the researchers have shown that it is associated with 90% of patients with duodenal ulcer and around 80% with gastric ulcers. The H.pylori tests include urea breath testing (UBT) which is the most prevalent type of testing for pylori, stool antigen testing, stomach biopsy are some of the tests. According to the research, 95-98% of patients are with duodenal ulcers and 60-90% of patients with gastric ulcers.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR4.8%


Market players are focusing on partnerships, collaborations, and new product launches in order to increase their offerings in the lightweight jackets market. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product offerings. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Helicobacter Pylori Testing market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Cardinal Health (United States), Sekisui Diagnostics LLC (United States), F. Hoffmann-La Roche Ltd. (Switzerland)', Medline Industries, Inc. (United States), Thermo Fisher Scientific (United States), Bio-Rad Laboratories, Inc.(United States), Meridian Bioscience Inc. (United States), Alpha Laboratories (United Kingdom), RedHill Biopharma Ltd. (Israel), Beckman Coulter, Inc.(United States) and EKF Diagnostics (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Quidel Corporation (United States) and CorisBioConcept SPR (Belgium).

Segmentation Overview
AMA Research has segmented the market of Global Helicobacter Pylori Testing market by Type (With Endoscopy and Without Endoscopy), Application (Physical Examination Center, Hospitals, Clinics and Others) and Region.



On the basis of geography, the market of Helicobacter Pylori Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Tests, the sub-segment i.e. Blood Antibody Test will boost the Helicobacter Pylori Testing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
The Urea Breath Test is most Common for Helicobacter Pylori and Helicobacter Pylori is common in Developing Countries Especially in South and East Europe

Market Growth Drivers:
The rising prevalence of variety of gastrointestinal diseases like gastritis, duodenal and gastric ulcers, non-ulcer dyspepsia, gastric adenocarcinoma, and lymphoma is driving the helicobacter pylori testing market. These tests are needed for further prevention from helicobacter pylori even in the case of minor symptoms.

Challenges:
Complexities with Helicobacter Pylori Testing Machines

Restraints:
Stringent Regulatory Guidelines Regarding the Helicobacter Pylori Testing and Side effects associated with Helicobacter Pylori Testing

Opportunities:
Continuous Research and Development in Helicobacter Pylori Testing and Raising Awareness about Helicobacter Pylori Disease and its Possible effects

Market Leaders and their expansionary development strategies
In September 2022, The FDA recently approved 2 novel, packaged drug products–– vonoprazan, amoxicillin, and clarithromycin (ACV; Voquezna Triple Pak) and vonoprazan and amoxicillin (Voquezna Dual Pak) for the treatment of Helicobacter pylori infection in adults.
In September 2023, The FDA approved a supplemental new drug application for the omeprazole/amoxicillin/rifabutin combination drug Talicia (Redhill Biopharma), used for H. pylori eradication, to be taken in a new dosing regimen of at least four hours apart with food.
"The American Gastroenterological Association (AGA), no longer recommends serology-based testing for diagnosing infection or evaluating treatment effectiveness as it is unable to distinguish between active infection and previous exposure to H. pylori, does not confirm eradication and has a poor positive predictive value when compared to active infection tests such as the urea breath test or stool antigen test."

Key Target Audience
Helicobacter Pylori Testing Device and Medicines Manufacturers, Helicobacter Pylori Testing Device International Traders, Helicobacter Pylori Testing Device Distributors and Suppliers, Regulatory Bodies, Research and Development Institutes, Hospitals, Potential Investors, Industry Associations and Other

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • With Endoscopy
  • Without Endoscopy
By Application
  • Physical Examination Center
  • Hospitals
  • Clinics
  • Others
By Tests
  • Blood Antibody Test
  • Urea Breath Test
  • Stool Antigen Test
  • Stomach Biopsy
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The rising prevalence of variety of gastrointestinal diseases like gastritis, duodenal and gastric ulcers, non-ulcer dyspepsia, gastric adenocarcinoma, and lymphoma is driving the helicobacter pylori testing market. These tests are needed for further prevention from helicobacter pylori even in the case of minor symptoms.
    • 3.3. Market Challenges
      • 3.3.1. Complexities with Helicobacter Pylori Testing Machines
    • 3.4. Market Trends
      • 3.4.1. The Urea Breath Test is most Common for Helicobacter Pylori
      • 3.4.2. Helicobacter Pylori is common in Developing Countries Especially in South and East Europe
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Helicobacter Pylori Testing, by Type, Application, Tests and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Helicobacter Pylori Testing (Value)
      • 5.2.1. Global Helicobacter Pylori Testing by: Type (Value)
        • 5.2.1.1. With Endoscopy
        • 5.2.1.2. Without Endoscopy
      • 5.2.2. Global Helicobacter Pylori Testing by: Application (Value)
        • 5.2.2.1. Physical Examination Center
        • 5.2.2.2. Hospitals
        • 5.2.2.3. Clinics
        • 5.2.2.4. Others
      • 5.2.3. Global Helicobacter Pylori Testing by: Tests (Value)
        • 5.2.3.1. Blood Antibody Test
        • 5.2.3.2. Urea Breath Test
        • 5.2.3.3. Stool Antigen Test
        • 5.2.3.4. Stomach Biopsy
        • 5.2.3.5. Others
      • 5.2.4. Global Helicobacter Pylori Testing Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Helicobacter Pylori Testing (Price)
      • 5.3.1. Global Helicobacter Pylori Testing by: Type (Price)
  • 6. Helicobacter Pylori Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cardinal Health (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sekisui Diagnostics LLC (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. F. Hoffmann-La Roche Ltd. (Switzerland)'
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Medline Industries, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Thermo Fisher Scientific (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bio-Rad Laboratories, Inc.(United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Meridian Bioscience Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Alpha Laboratories (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. RedHill Biopharma Ltd. (Israel)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Beckman Coulter, Inc.(United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. EKF Diagnostics (United Kingdom)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Helicobacter Pylori Testing Sale, by Type, Application, Tests and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Helicobacter Pylori Testing (Value)
      • 7.2.1. Global Helicobacter Pylori Testing by: Type (Value)
        • 7.2.1.1. With Endoscopy
        • 7.2.1.2. Without Endoscopy
      • 7.2.2. Global Helicobacter Pylori Testing by: Application (Value)
        • 7.2.2.1. Physical Examination Center
        • 7.2.2.2. Hospitals
        • 7.2.2.3. Clinics
        • 7.2.2.4. Others
      • 7.2.3. Global Helicobacter Pylori Testing by: Tests (Value)
        • 7.2.3.1. Blood Antibody Test
        • 7.2.3.2. Urea Breath Test
        • 7.2.3.3. Stool Antigen Test
        • 7.2.3.4. Stomach Biopsy
        • 7.2.3.5. Others
      • 7.2.4. Global Helicobacter Pylori Testing Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Helicobacter Pylori Testing (Price)
      • 7.3.1. Global Helicobacter Pylori Testing by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Helicobacter Pylori Testing: by Type(USD Million)
  • Table 2. Helicobacter Pylori Testing With Endoscopy , by Region USD Million (2018-2023)
  • Table 3. Helicobacter Pylori Testing Without Endoscopy , by Region USD Million (2018-2023)
  • Table 4. Helicobacter Pylori Testing: by Application(USD Million)
  • Table 5. Helicobacter Pylori Testing Physical Examination Center , by Region USD Million (2018-2023)
  • Table 6. Helicobacter Pylori Testing Hospitals , by Region USD Million (2018-2023)
  • Table 7. Helicobacter Pylori Testing Clinics , by Region USD Million (2018-2023)
  • Table 8. Helicobacter Pylori Testing Others , by Region USD Million (2018-2023)
  • Table 9. Helicobacter Pylori Testing: by Tests(USD Million)
  • Table 10. Helicobacter Pylori Testing Blood Antibody Test , by Region USD Million (2018-2023)
  • Table 11. Helicobacter Pylori Testing Urea Breath Test , by Region USD Million (2018-2023)
  • Table 12. Helicobacter Pylori Testing Stool Antigen Test , by Region USD Million (2018-2023)
  • Table 13. Helicobacter Pylori Testing Stomach Biopsy , by Region USD Million (2018-2023)
  • Table 14. Helicobacter Pylori Testing Others , by Region USD Million (2018-2023)
  • Table 15. South America Helicobacter Pylori Testing, by Country USD Million (2018-2023)
  • Table 16. South America Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 17. South America Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 18. South America Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 19. Brazil Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 20. Brazil Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 21. Brazil Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 22. Argentina Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 23. Argentina Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 24. Argentina Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 25. Rest of South America Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 26. Rest of South America Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 27. Rest of South America Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 28. Asia Pacific Helicobacter Pylori Testing, by Country USD Million (2018-2023)
  • Table 29. Asia Pacific Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 30. Asia Pacific Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 31. Asia Pacific Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 32. China Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 33. China Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 34. China Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 35. Japan Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 36. Japan Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 37. Japan Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 38. India Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 39. India Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 40. India Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 41. South Korea Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 42. South Korea Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 43. South Korea Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 44. Taiwan Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 45. Taiwan Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 46. Taiwan Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 47. Australia Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 48. Australia Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 49. Australia Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 53. Europe Helicobacter Pylori Testing, by Country USD Million (2018-2023)
  • Table 54. Europe Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 55. Europe Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 56. Europe Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 57. Germany Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 58. Germany Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 59. Germany Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 60. France Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 61. France Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 62. France Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 63. Italy Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 64. Italy Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 65. Italy Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 66. United Kingdom Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 67. United Kingdom Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 68. United Kingdom Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 69. Netherlands Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 70. Netherlands Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 71. Netherlands Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 72. Rest of Europe Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 73. Rest of Europe Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 74. Rest of Europe Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 75. MEA Helicobacter Pylori Testing, by Country USD Million (2018-2023)
  • Table 76. MEA Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 77. MEA Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 78. MEA Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 79. Middle East Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 80. Middle East Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 81. Middle East Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 82. Africa Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 83. Africa Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 84. Africa Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 85. North America Helicobacter Pylori Testing, by Country USD Million (2018-2023)
  • Table 86. North America Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 87. North America Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 88. North America Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 89. United States Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 90. United States Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 91. United States Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 92. Canada Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 93. Canada Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 94. Canada Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 95. Mexico Helicobacter Pylori Testing, by Type USD Million (2018-2023)
  • Table 96. Mexico Helicobacter Pylori Testing, by Application USD Million (2018-2023)
  • Table 97. Mexico Helicobacter Pylori Testing, by Tests USD Million (2018-2023)
  • Table 98. Helicobacter Pylori Testing: by Type(USD/Units)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Helicobacter Pylori Testing: by Type(USD Million)
  • Table 111. Helicobacter Pylori Testing With Endoscopy , by Region USD Million (2025-2030)
  • Table 112. Helicobacter Pylori Testing Without Endoscopy , by Region USD Million (2025-2030)
  • Table 113. Helicobacter Pylori Testing: by Application(USD Million)
  • Table 114. Helicobacter Pylori Testing Physical Examination Center , by Region USD Million (2025-2030)
  • Table 115. Helicobacter Pylori Testing Hospitals , by Region USD Million (2025-2030)
  • Table 116. Helicobacter Pylori Testing Clinics , by Region USD Million (2025-2030)
  • Table 117. Helicobacter Pylori Testing Others , by Region USD Million (2025-2030)
  • Table 118. Helicobacter Pylori Testing: by Tests(USD Million)
  • Table 119. Helicobacter Pylori Testing Blood Antibody Test , by Region USD Million (2025-2030)
  • Table 120. Helicobacter Pylori Testing Urea Breath Test , by Region USD Million (2025-2030)
  • Table 121. Helicobacter Pylori Testing Stool Antigen Test , by Region USD Million (2025-2030)
  • Table 122. Helicobacter Pylori Testing Stomach Biopsy , by Region USD Million (2025-2030)
  • Table 123. Helicobacter Pylori Testing Others , by Region USD Million (2025-2030)
  • Table 124. South America Helicobacter Pylori Testing, by Country USD Million (2025-2030)
  • Table 125. South America Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 126. South America Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 127. South America Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 128. Brazil Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 129. Brazil Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 130. Brazil Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 131. Argentina Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 132. Argentina Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 133. Argentina Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 134. Rest of South America Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 135. Rest of South America Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 136. Rest of South America Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 137. Asia Pacific Helicobacter Pylori Testing, by Country USD Million (2025-2030)
  • Table 138. Asia Pacific Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 139. Asia Pacific Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 140. Asia Pacific Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 141. China Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 142. China Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 143. China Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 144. Japan Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 145. Japan Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 146. Japan Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 147. India Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 148. India Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 149. India Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 150. South Korea Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 151. South Korea Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 152. South Korea Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 153. Taiwan Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 154. Taiwan Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 155. Taiwan Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 156. Australia Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 157. Australia Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 158. Australia Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 159. Rest of Asia-Pacific Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 160. Rest of Asia-Pacific Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 161. Rest of Asia-Pacific Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 162. Europe Helicobacter Pylori Testing, by Country USD Million (2025-2030)
  • Table 163. Europe Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 164. Europe Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 165. Europe Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 166. Germany Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 167. Germany Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 168. Germany Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 169. France Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 170. France Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 171. France Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 172. Italy Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 173. Italy Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 174. Italy Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 175. United Kingdom Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 176. United Kingdom Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 177. United Kingdom Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 178. Netherlands Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 179. Netherlands Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 180. Netherlands Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 181. Rest of Europe Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 182. Rest of Europe Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 183. Rest of Europe Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 184. MEA Helicobacter Pylori Testing, by Country USD Million (2025-2030)
  • Table 185. MEA Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 186. MEA Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 187. MEA Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 188. Middle East Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 189. Middle East Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 190. Middle East Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 191. Africa Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 192. Africa Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 193. Africa Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 194. North America Helicobacter Pylori Testing, by Country USD Million (2025-2030)
  • Table 195. North America Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 196. North America Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 197. North America Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 198. United States Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 199. United States Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 200. United States Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 201. Canada Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 202. Canada Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 203. Canada Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 204. Mexico Helicobacter Pylori Testing, by Type USD Million (2025-2030)
  • Table 205. Mexico Helicobacter Pylori Testing, by Application USD Million (2025-2030)
  • Table 206. Mexico Helicobacter Pylori Testing, by Tests USD Million (2025-2030)
  • Table 207. Helicobacter Pylori Testing: by Type(USD/Units)
  • Table 208. Research Programs/Design for This Report
  • Table 209. Key Data Information from Secondary Sources
  • Table 210. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Helicobacter Pylori Testing: by Type USD Million (2018-2023)
  • Figure 5. Global Helicobacter Pylori Testing: by Application USD Million (2018-2023)
  • Figure 6. Global Helicobacter Pylori Testing: by Tests USD Million (2018-2023)
  • Figure 7. South America Helicobacter Pylori Testing Share (%), by Country
  • Figure 8. Asia Pacific Helicobacter Pylori Testing Share (%), by Country
  • Figure 9. Europe Helicobacter Pylori Testing Share (%), by Country
  • Figure 10. MEA Helicobacter Pylori Testing Share (%), by Country
  • Figure 11. North America Helicobacter Pylori Testing Share (%), by Country
  • Figure 12. Global Helicobacter Pylori Testing: by Type USD/Units (2018-2023)
  • Figure 13. Global Helicobacter Pylori Testing share by Players 2023 (%)
  • Figure 14. Global Helicobacter Pylori Testing share by Players (Top 3) 2023(%)
  • Figure 15. Global Helicobacter Pylori Testing share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Cardinal Health (United States) Revenue, Net Income and Gross profit
  • Figure 18. Cardinal Health (United States) Revenue: by Geography 2023
  • Figure 19. Sekisui Diagnostics LLC (United States) Revenue, Net Income and Gross profit
  • Figure 20. Sekisui Diagnostics LLC (United States) Revenue: by Geography 2023
  • Figure 21. F. Hoffmann-La Roche Ltd. (Switzerland)' Revenue, Net Income and Gross profit
  • Figure 22. F. Hoffmann-La Roche Ltd. (Switzerland)' Revenue: by Geography 2023
  • Figure 23. Medline Industries, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Medline Industries, Inc. (United States) Revenue: by Geography 2023
  • Figure 25. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 26. Thermo Fisher Scientific (United States) Revenue: by Geography 2023
  • Figure 27. Bio-Rad Laboratories, Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 28. Bio-Rad Laboratories, Inc.(United States) Revenue: by Geography 2023
  • Figure 29. Meridian Bioscience Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Meridian Bioscience Inc. (United States) Revenue: by Geography 2023
  • Figure 31. Alpha Laboratories (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Alpha Laboratories (United Kingdom) Revenue: by Geography 2023
  • Figure 33. RedHill Biopharma Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 34. RedHill Biopharma Ltd. (Israel) Revenue: by Geography 2023
  • Figure 35. Beckman Coulter, Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 36. Beckman Coulter, Inc.(United States) Revenue: by Geography 2023
  • Figure 37. EKF Diagnostics (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 38. EKF Diagnostics (United Kingdom) Revenue: by Geography 2023
  • Figure 39. Global Helicobacter Pylori Testing: by Type USD Million (2025-2030)
  • Figure 40. Global Helicobacter Pylori Testing: by Application USD Million (2025-2030)
  • Figure 41. Global Helicobacter Pylori Testing: by Tests USD Million (2025-2030)
  • Figure 42. South America Helicobacter Pylori Testing Share (%), by Country
  • Figure 43. Asia Pacific Helicobacter Pylori Testing Share (%), by Country
  • Figure 44. Europe Helicobacter Pylori Testing Share (%), by Country
  • Figure 45. MEA Helicobacter Pylori Testing Share (%), by Country
  • Figure 46. North America Helicobacter Pylori Testing Share (%), by Country
  • Figure 47. Global Helicobacter Pylori Testing: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Cardinal Health (United States)
  • Sekisui Diagnostics LLC (United States)
  • F. Hoffmann-La Roche Ltd. (Switzerland)'
  • Medline Industries, Inc. (United States)
  • Thermo Fisher Scientific (United States)
  • Bio-Rad Laboratories, Inc.(United States)
  • Meridian Bioscience Inc. (United States)
  • Alpha Laboratories (United Kingdom)
  • RedHill Biopharma Ltd. (Israel)
  • Beckman Coulter, Inc.(United States)
  • EKF Diagnostics (United Kingdom)
Additional players considered in the study are as follows:
Quidel Corporation (United States) , CorisBioConcept SPR (Belgium)
Select User Access Type

Key Highlights of Report


Apr 2024 236 Pages 54 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Helicobacter Pylori Testing Market Quantitative research analysis
Global Helicobacter Pylori Testing Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Cardinal Health (United States), Sekisui Diagnostics LLC (United States), F. Hoffmann-La Roche Ltd. (Switzerland)', Medline Industries, Inc. (United States), Thermo Fisher Scientific (United States), Bio-Rad Laboratories, Inc.(United States), Meridian Bioscience Inc. (United States), Alpha Laboratories (United Kingdom), RedHill Biopharma Ltd. (Israel), Beckman Coulter, Inc.(United States) and EKF Diagnostics (United Kingdom) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"The Urea Breath Test is most Common for Helicobacter Pylori " is seen as one of major influencing trends for Helicobacter Pylori Testing Market during projected period 2023-2030.
The Helicobacter Pylori Testing market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Helicobacter Pylori Testing Market Report?

Have a Query? Click Here

Other Related Reports

Transcatheter Mitral Valve Repair and Replacement Comprehensive Study by Type (Transcatheter Mitral Valve Repair, Transcatheter Mitral Valve Replacement), Application (Hospitals, Clinics, Others), Pr...
$ 3650
mHealth Solutions Comprehensive Study by Type (Wellness Service, Monitoring Service, Diagnostic Service, Treatment, Information and reference), Application (General Healthcare and Fitness, Medication...
$ 3750
Facial Implants Comprehensive Study by Type (Silicone facial implants, EPTFE implants and sheeting), Application (Hospitals, Super specialty clinics, Ambulatory Surgical Centers), Product (Chin impla...
$ 3450
Organ Preservation Comprehensive Study by Type (Kidneys, Liver, Lung, Heart, Others (Intestine & Pancreas)), Application (Medical Research, Hospital, Organ Transplantation), Organism (Human, Animal),...
$ 3750
Medical Waste Containers Comprehensive Study by Type (Chemotherapy, Biohazardous, Sharps, RCRA), Waste (General Medical Waste, Infectious Medical Waste, Hazardous Medical Waste, Others), End User (Ho...
$ 3350
Blood Bag Label Comprehensive Study by Type (Primary Label, Secondary Label), Application (Blood Banks, Hospitals, Other), Label Color (White, Yellow, Blue, Translucent, Others), Core Size (1 Inch, 3...
$ 3650